Preparation, characterization and in vitro evaluation of phosphate-doped bioactive glass nanoparticles as promising candidates for therapeutic applications
- PMID: 40537827
- PMCID: PMC12180270
- DOI: 10.1186/s13065-025-01543-w
Preparation, characterization and in vitro evaluation of phosphate-doped bioactive glass nanoparticles as promising candidates for therapeutic applications
Abstract
This research focuses on synthesizing bioactive glass nanoparticles with different phosphate concentrations to evaluate their physicochemical characteristics and explore their biomedical potential. The nanoparticles were fabricated by melting a mixture of silica, calcium oxide, sodium oxide, and ammonium dihydrogen phosphate at 1450 °C, followed by ball milling to obtain the optimal particle size distribution. The study systematically investigated the effect of phosphate content on the nanoparticles' structural properties and bioactive performance. Advanced characterization methods; such as XRD, FTIR, DTA, and FE-SEM-EDX were used to examine structural stability and phosphate-induced surface alterations. In vitro assays revealed dose-dependent antioxidant, anti-diabetic, anti-Alzheimer's, anti-arthritic, and anti-inflammatory activities, with higher phosphate content enhancing bioactivity. Results demonstrated enhanced radical scavenging and enzyme inhibition in samples with higher phosphate levels. These findings suggest that phosphate-doped bioactive glass nanoparticles hold significant promise for therapeutic applications. The research advances the understanding of how synthesis parameters influence bioactivity, providing valuable insights for designing next-generation biomedical materials.
Keywords: Antioxidant and anti-inflammatory effects; Bioactive glass nanoparticles; Biomedical applications; In vitro bioactivity; Phosphate doping.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Ethical approval was not required for this study as it did not involve human participants, animal subjects, or sensitive data. All study participants provided written informed consent. Participants received information on the study’s objectives, the steps involved, and their freedom to discontinue participation at any moment without facing any repercussions. Throughout the duration of the study, participants’ information was kept completely private. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures





Similar articles
-
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159. Cochrane Database Syst Rev. 2001. PMID: 11687175 Free PMC article.
-
How lived experiences of illness trajectories, burdens of treatment, and social inequalities shape service user and caregiver participation in health and social care: a theory-informed qualitative evidence synthesis.Health Soc Care Deliv Res. 2025 Jun;13(24):1-120. doi: 10.3310/HGTQ8159. Health Soc Care Deliv Res. 2025. PMID: 40548558
-
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280. Health Technol Assess. 2008. PMID: 18547499
-
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001230. doi: 10.1002/14651858.CD001230.pub2. Cochrane Database Syst Rev. 2008. PMID: 18646068
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
References
-
- Başaran E, Çakmak R, Türkmenoğlu B, Akkoc S, Köprü S. Synthesis of sulfonamide-based schiff bases as potent anticancer agents: spectral analyses, biological activity, molecular docking, ADME, DFT, and pharmacophore modelling studies. Chem Biodivers. 2024;22:2. - PubMed
-
- Çakmak R, Ay B, Çınar E, Başaran E, Akkoç S, Boğa M, Taş E. Synthesis, spectroscopic, thermal analysis and in vitro cytotoxicity, anticholinesterase and antioxidant activities of new Co(II), Ni(II), Cu(II), Zn(II), and Ru(III) complexes of pyrazolone-based Schiff base ligand. J Mol Struct. 2023;1292: 136225.
-
- Farzaliyev V, Ertürk A, Huseynova A, Demir Y, Kızıltaş H, Sujayev A, İsakov MA, Ibrahimova B, Gülçin I. Some novel oxirane-thiirane derivatives: synthesis, molecular docking and enzymatic inhibition for therapeutic potential. Cell Biochem Biophys. 2025;21: e202401849. - PubMed
-
- Nasab NH, Raza H, Eom YS, Shah FH, Kwak J-H, Kim SJ. Exploring chalcone-sulfonyl piperazine hybrids as anti-diabetes candidates: design, synthesis, biological evaluation, and molecular docking study. Mol Divers. 2025;29:43–59. - PubMed
-
- Hegazi NM, El Shabrawy M, Aboulthana WM, Ragheb AY, Ibrahim LF, Marzouk MM. UPLC-HRMS/MS Guided Isolation and NMR Investigation of Major Flavonoids from Enarthrocarpus strangulatus Boissier (Brassicaceae) with In Vitro Enzymes Inhibitory Potential. Chem Biodivers. 2025;22: e202401402. - PubMed
LinkOut - more resources
Full Text Sources